Copyright Reports & Markets. All rights reserved.

Global Generic Injection Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Generic Injection Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Liquid Injection
    • 1.2.3 Powder for Injection
  • 1.3 Market by Application
    • 1.3.1 Global Generic Injection Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Hospital
    • 1.3.3 Clinic
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Generic Injection Market Perspective (2016-2027)
  • 2.2 Generic Injection Growth Trends by Regions
    • 2.2.1 Generic Injection Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Generic Injection Historic Market Share by Regions (2016-2021)
    • 2.2.3 Generic Injection Forecasted Market Size by Regions (2022-2027)
  • 2.3 Generic Injection Industry Dynamic
    • 2.3.1 Generic Injection Market Trends
    • 2.3.2 Generic Injection Market Drivers
    • 2.3.3 Generic Injection Market Challenges
    • 2.3.4 Generic Injection Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Generic Injection Players by Revenue
    • 3.1.1 Global Top Generic Injection Players by Revenue (2016-2021)
    • 3.1.2 Global Generic Injection Revenue Market Share by Players (2016-2021)
  • 3.2 Global Generic Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Generic Injection Revenue
  • 3.4 Global Generic Injection Market Concentration Ratio
    • 3.4.1 Global Generic Injection Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Generic Injection Revenue in 2020
  • 3.5 Generic Injection Key Players Head office and Area Served
  • 3.6 Key Players Generic Injection Product Solution and Service
  • 3.7 Date of Enter into Generic Injection Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Generic Injection Breakdown Data by Type

  • 4.1 Global Generic Injection Historic Market Size by Type (2016-2021)
  • 4.2 Global Generic Injection Forecasted Market Size by Type (2022-2027)

5 Generic Injection Breakdown Data by Application

  • 5.1 Global Generic Injection Historic Market Size by Application (2016-2021)
  • 5.2 Global Generic Injection Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Generic Injection Market Size (2016-2027)
  • 6.2 North America Generic Injection Market Size by Type
    • 6.2.1 North America Generic Injection Market Size by Type (2016-2021)
    • 6.2.2 North America Generic Injection Market Size by Type (2022-2027)
    • 6.2.3 North America Generic Injection Market Size by Type (2016-2027)
  • 6.3 North America Generic Injection Market Size by Application
    • 6.3.1 North America Generic Injection Market Size by Application (2016-2021)
    • 6.3.2 North America Generic Injection Market Size by Application (2022-2027)
    • 6.3.3 North America Generic Injection Market Size by Application (2016-2027)
  • 6.4 North America Generic Injection Market Size by Country
    • 6.4.1 North America Generic Injection Market Size by Country (2016-2021)
    • 6.4.2 North America Generic Injection Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Generic Injection Market Size (2016-2027)
  • 7.2 Europe Generic Injection Market Size by Type
    • 7.2.1 Europe Generic Injection Market Size by Type (2016-2021)
    • 7.2.2 Europe Generic Injection Market Size by Type (2022-2027)
    • 7.2.3 Europe Generic Injection Market Size by Type (2016-2027)
  • 7.3 Europe Generic Injection Market Size by Application
    • 7.3.1 Europe Generic Injection Market Size by Application (2016-2021)
    • 7.3.2 Europe Generic Injection Market Size by Application (2022-2027)
    • 7.3.3 Europe Generic Injection Market Size by Application (2016-2027)
  • 7.4 Europe Generic Injection Market Size by Country
    • 7.4.1 Europe Generic Injection Market Size by Country (2016-2021)
    • 7.4.2 Europe Generic Injection Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Generic Injection Market Size (2016-2027)
  • 8.2 Asia-Pacific Generic Injection Market Size by Type
    • 8.2.1 Asia-Pacific Generic Injection Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Generic Injection Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Generic Injection Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Generic Injection Market Size by Application
    • 8.3.1 Asia-Pacific Generic Injection Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Generic Injection Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Generic Injection Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Generic Injection Market Size by Region
    • 8.4.1 Asia-Pacific Generic Injection Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Generic Injection Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Generic Injection Market Size (2016-2027)
  • 9.2 Latin America Generic Injection Market Size by Type
    • 9.2.1 Latin America Generic Injection Market Size by Type (2016-2021)
    • 9.2.2 Latin America Generic Injection Market Size by Type (2022-2027)
    • 9.2.3 Latin America Generic Injection Market Size by Type (2016-2027)
  • 9.3 Latin America Generic Injection Market Size by Application
    • 9.3.1 Latin America Generic Injection Market Size by Application (2016-2021)
    • 9.3.2 Latin America Generic Injection Market Size by Application (2022-2027)
    • 9.3.3 Latin America Generic Injection Market Size by Application (2016-2027)
  • 9.4 Latin America Generic Injection Market Size by Country
    • 9.4.1 Latin America Generic Injection Market Size by Country (2016-2021)
    • 9.4.2 Latin America Generic Injection Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Generic Injection Market Size (2016-2027)
  • 10.2 Middle East & Africa Generic Injection Market Size by Type
    • 10.2.1 Middle East & Africa Generic Injection Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Generic Injection Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Generic Injection Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Generic Injection Market Size by Application
    • 10.3.1 Middle East & Africa Generic Injection Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Generic Injection Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Generic Injection Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Generic Injection Market Size by Country
    • 10.4.1 Middle East & Africa Generic Injection Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Generic Injection Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Sanofi
    • 11.1.1 Sanofi Company Details
    • 11.1.2 Sanofi Business Overview
    • 11.1.3 Sanofi Generic Injection Introduction
    • 11.1.4 Sanofi Revenue in Generic Injection Business (2016-2021)
    • 11.1.5 Sanofi Recent Development
  • 11.2 Fresenius
    • 11.2.1 Fresenius Company Details
    • 11.2.2 Fresenius Business Overview
    • 11.2.3 Fresenius Generic Injection Introduction
    • 11.2.4 Fresenius Revenue in Generic Injection Business (2016-2021)
    • 11.2.5 Fresenius Recent Development
  • 11.3 Viatris
    • 11.3.1 Viatris Company Details
    • 11.3.2 Viatris Business Overview
    • 11.3.3 Viatris Generic Injection Introduction
    • 11.3.4 Viatris Revenue in Generic Injection Business (2016-2021)
    • 11.3.5 Viatris Recent Development
  • 11.4 Pfizer
    • 11.4.1 Pfizer Company Details
    • 11.4.2 Pfizer Business Overview
    • 11.4.3 Pfizer Generic Injection Introduction
    • 11.4.4 Pfizer Revenue in Generic Injection Business (2016-2021)
    • 11.4.5 Pfizer Recent Development
  • 11.5 Teva Pharmaceuticals
    • 11.5.1 Teva Pharmaceuticals Company Details
    • 11.5.2 Teva Pharmaceuticals Business Overview
    • 11.5.3 Teva Pharmaceuticals Generic Injection Introduction
    • 11.5.4 Teva Pharmaceuticals Revenue in Generic Injection Business (2016-2021)
    • 11.5.5 Teva Pharmaceuticals Recent Development
  • 11.6 Hikma Pharmaceuticals
    • 11.6.1 Hikma Pharmaceuticals Company Details
    • 11.6.2 Hikma Pharmaceuticals Business Overview
    • 11.6.3 Hikma Pharmaceuticals Generic Injection Introduction
    • 11.6.4 Hikma Pharmaceuticals Revenue in Generic Injection Business (2016-2021)
    • 11.6.5 Hikma Pharmaceuticals Recent Development
  • 11.7 Novartis
    • 11.7.1 Novartis Company Details
    • 11.7.2 Novartis Business Overview
    • 11.7.3 Novartis Generic Injection Introduction
    • 11.7.4 Novartis Revenue in Generic Injection Business (2016-2021)
    • 11.7.5 Novartis Recent Development
  • 11.8 Amneal Pharmaceuticals
    • 11.8.1 Amneal Pharmaceuticals Company Details
    • 11.8.2 Amneal Pharmaceuticals Business Overview
    • 11.8.3 Amneal Pharmaceuticals Generic Injection Introduction
    • 11.8.4 Amneal Pharmaceuticals Revenue in Generic Injection Business (2016-2021)
    • 11.8.5 Amneal Pharmaceuticals Recent Development
  • 11.9 Gland Pharma
    • 11.9.1 Gland Pharma Company Details
    • 11.9.2 Gland Pharma Business Overview
    • 11.9.3 Gland Pharma Generic Injection Introduction
    • 11.9.4 Gland Pharma Revenue in Generic Injection Business (2016-2021)
    • 11.9.5 Gland Pharma Recent Development
  • 11.10 Allergan
    • 11.10.1 Allergan Company Details
    • 11.10.2 Allergan Business Overview
    • 11.10.3 Allergan Generic Injection Introduction
    • 11.10.4 Allergan Revenue in Generic Injection Business (2016-2021)
    • 11.10.5 Allergan Recent Development
  • 11.11 Kelun Pharmaceutical
    • 11.11.1 Kelun Pharmaceutical Company Details
    • 11.11.2 Kelun Pharmaceutical Business Overview
    • 11.11.3 Kelun Pharmaceutical Generic Injection Introduction
    • 11.11.4 Kelun Pharmaceutical Revenue in Generic Injection Business (2016-2021)
    • 11.11.5 Kelun Pharmaceutical Recent Development
  • 11.12 Jiangsu HRS
    • 11.12.1 Jiangsu HRS Company Details
    • 11.12.2 Jiangsu HRS Business Overview
    • 11.12.3 Jiangsu HRS Generic Injection Introduction
    • 11.12.4 Jiangsu HRS Revenue in Generic Injection Business (2016-2021)
    • 11.12.5 Jiangsu HRS Recent Development
  • 11.13 Qilu Pharmaceutical
    • 11.13.1 Qilu Pharmaceutical Company Details
    • 11.13.2 Qilu Pharmaceutical Business Overview
    • 11.13.3 Qilu Pharmaceutical Generic Injection Introduction
    • 11.13.4 Qilu Pharmaceutical Revenue in Generic Injection Business (2016-2021)
    • 11.13.5 Qilu Pharmaceutical Recent Development
  • 11.14 Chiatai Tianqing
    • 11.14.1 Chiatai Tianqing Company Details
    • 11.14.2 Chiatai Tianqing Business Overview
    • 11.14.3 Chiatai Tianqing Generic Injection Introduction
    • 11.14.4 Chiatai Tianqing Revenue in Generic Injection Business (2016-2021)
    • 11.14.5 Chiatai Tianqing Recent Development
  • 11.15 Hainan Poly Pharm
    • 11.15.1 Hainan Poly Pharm Company Details
    • 11.15.2 Hainan Poly Pharm Business Overview
    • 11.15.3 Hainan Poly Pharm Generic Injection Introduction
    • 11.15.4 Hainan Poly Pharm Revenue in Generic Injection Business (2016-2021)
    • 11.15.5 Hainan Poly Pharm Recent Development
  • 11.16 Yangzijiang Pharmaceutical Industry
    • 11.16.1 Yangzijiang Pharmaceutical Industry Company Details
    • 11.16.2 Yangzijiang Pharmaceutical Industry Business Overview
    • 11.16.3 Yangzijiang Pharmaceutical Industry Generic Injection Introduction
    • 11.16.4 Yangzijiang Pharmaceutical Industry Revenue in Generic Injection Business (2016-2021)
    • 11.16.5 Yangzijiang Pharmaceutical Industry Recent Development
  • 11.17 Shijiazhuang Pharma Group
    • 11.17.1 Shijiazhuang Pharma Group Company Details
    • 11.17.2 Shijiazhuang Pharma Group Business Overview
    • 11.17.3 Shijiazhuang Pharma Group Generic Injection Introduction
    • 11.17.4 Shijiazhuang Pharma Group Revenue in Generic Injection Business (2016-2021)
    • 11.17.5 Shijiazhuang Pharma Group Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Generic Injection Scope and Market Size
    Generic Injection market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Generic Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Liquid Injection
    Powder for Injection

    Segment by Application
    Hospital
    Clinic
    Others

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Sanofi
    Fresenius
    Viatris
    Pfizer
    Teva Pharmaceuticals
    Hikma Pharmaceuticals
    Novartis
    Amneal Pharmaceuticals
    Gland Pharma
    Allergan
    Kelun Pharmaceutical
    Jiangsu HRS
    Qilu Pharmaceutical
    Chiatai Tianqing
    Hainan Poly Pharm
    Yangzijiang Pharmaceutical Industry
    Shijiazhuang Pharma Group

    Buy now